State of the science: beta-blockers and reduction of perioperative cardiac events.
This article evaluates the current literature concerning the use of perioperative beta-blockade to reduce cardiac events in hopes that it may provide direction to clinicians or demonstrate gaps in medical knowledge, thus revealing areas suitable for future study. The current standard of practice for the use of perioperative beta-blockade in preoperative patients is outlined in the American College of Cardiology (ACC) and American Heart Association (AHA) guidelines. Findings differ as to the risk and benefit of using beta-blockers perioperatively to reduce cardiac events. Further research is needed to support the ACC/AHA recommendations. It is essential that the decision to use beta-blockade be made on a case-by-case basis with adequate risk stratification as part of the criteria.